Nykode Therapeutics AS

OSL-NYKD
Oslo Børs NYSE
Healthcare Biotechnology
Global Rank
#28602
Country Rank
#181
Market Cap
55.53 M
Price
0.17
Change (%)
0.12%
Volume
254,192

Nykode Therapeutics AS's latest marketcap:

55.53 M

As of 06/07/2025, Nykode Therapeutics AS's market capitalization has reached $55.53 M. According to our data, Nykode Therapeutics AS is the 28602th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 55.53 M
Revenue (ttm) 8.61 M
Net Income (ttm) -26,336,335.59
Shares Out 326.55 M
EPS (ttm) -0.08
Forward PE 0.00
Ex-Dividend Date 05/27/2025
Earnings Date 05/28/2025
Market Cap Chart
Data Updated: 06/07/2025

Nykode Therapeutics AS's yearly market capitalization.

Nykode Therapeutics AS has seen its market value drop from kr21.36 B to kr561.66 M since 2020, representing a total decrease of 97.37% and an annual compound decline rate (CAGR) of 55.96%.
Date Market Cap Change (%)
06/07/2025 kr561.66 M -43.47%
12/30/2024 kr994.66 M -85.77%
12/29/2023 kr6.99 B -15.67%
12/30/2022 kr8.29 B -64.54%
12/30/2021 kr23.37 B 9.44%
12/30/2020 kr21.36 B

Company Profile

Nykode Therapeutics AS was founded in 2006 in Norway. on the Oslo Børs. With 136 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.